From January 1, 2024 to March 31, 2024, the company has repurchased 1,148,000 shares, representing 0.67% for CNY 13.11 million. With this, the company has completed the repurchase of 1,872,500 shares, representing 1.1% for CNY 22.08 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.7 CNY | +7.24% | +26.49% | -19.70% |
1st Jan change | Capi. | |
---|---|---|
-19.70% | 255M | |
+11.32% | 7.78B | |
+1.64% | 7.38B | |
+10.50% | 6.52B | |
-6.69% | 3.67B | |
-13.51% | 3.44B | |
-10.10% | 1.17B | |
+8.34% | 934M | |
-41.81% | 879M | |
-19.81% | 836M |
- Stock Market
- Equities
- 603079 Stock
- News Zhejiang Shengda Bio-Pharm Co., Ltd.
- Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.